How to Check Whether a Stem Cell Clinic's Cited Research Actually Supports Its Claims

What this article covers
- Peer-Reviewed Journal Article, or Something Else Entirely?
- Not everything that looks like a citation has gone through peer review. Clinics sometimes link to conference abstracts, preprints that haven't been reviewed, white papers published on their own website, or press releases about a study rather than the study itself.
- Does the Study Actually Match What's Being Sold?
- This is the step most often skipped. A citation can be real and peer-reviewed and still not support the claim being made, if it tested a different condition, a different cell source, a different delivery method, or a different dose than what the clinic offers.
- Animal and Lab Studies Are Not Human Evidence
- One of the most consistent patterns regulators have flagged is clinics presenting preclinical research — studies done in mice, rats, or cell cultures — as if it demonstrates a treatment works in people. In a 2018 Federal Trade Commission case against a California physician and his companies, the FTC's complaint alleged the defendants knew "the vast majority of amniotic stem cell research has been conducted on animal models," while marketing the same injections to patients as a treatment for autism, Parkinson's disease, cerebral palsy, and blindness — claims the complaint says were not backed by any human clinical studies, including a claim that the therapy restored vision in a 101-year-old patient who had been blind for seven years.
- Case Series Are Not the Same as Controlled Evidence
- Clinics also frequently cite "published" case series — accounts of a handful of patients who were treated and report an outcome, with no control group for comparison. Case series sit near the bottom of the evidence hierarchy used in medicine specifically because they can't rule out whether patients would have improved anyway, from the placebo effect, from a concurrent treatment, or simply over time.
- Who Funded and Conducted the Study?
- Funding and authorship matter. A study funded by the company selling the product, or authored by physicians with a financial stake in the clinic citing it, isn't automatically wrong — but it should be weighed differently than independent, externally funded research, and a credible citation page will disclose funding sources rather than omit them.
Many stem cell clinic websites now include a "research" or "science" page listing studies, journal citations, or links to PubMed. That's a genuinely good sign compared to a site with no citations at all — but citing research and that research actually supporting the specific treatment being sold are two very different things. This article walks through the concrete questions to ask before taking a clinic's cited science at face value: whether the study was actually published and peer-reviewed, whether it tested the same condition, cell type, and dose being offered, whether it was conducted in humans at all, and how to pull up the original source yourself in a few minutes rather than relying on a clinic's summary of it.
Peer-Reviewed Journal Article, or Something Else Entirely?
Not everything that looks like a citation has gone through peer review. Clinics sometimes link to conference abstracts, preprints that haven't been reviewed, white papers published on their own website, or press releases about a study rather than the study itself. A quick way to check: search the study's title or authors directly in PubMed (pubmed.ncbi.nlm.nih.gov) or Google Scholar. If it doesn't appear in PubMed and isn't published in a journal you can identify, it likely hasn't cleared peer review — the process in which independent experts evaluate a study's methods and conclusions before a journal accepts it. Peer review doesn't guarantee a study is correct, but its absence means the findings haven't been externally checked at all.
Does the Study Actually Match What's Being Sold?
This is the step most often skipped. A citation can be real and peer-reviewed and still not support the claim being made, if it tested a different condition, a different cell source, a different delivery method, or a different dose than what the clinic offers. A study on mesenchymal stem cells injected into a knee for osteoarthritis says nothing about whether the same cells delivered intravenously will help a neurological condition. Read the study's own methods section — not the clinic's summary of it — to see exactly what was tested, on whom, and how.
Animal and Lab Studies Are Not Human Evidence
One of the most consistent patterns regulators have flagged is clinics presenting preclinical research — studies done in mice, rats, or cell cultures — as if it demonstrates a treatment works in people. In a 2018 Federal Trade Commission case against a California physician and his companies, the FTC's complaint alleged the defendants knew "the vast majority of amniotic stem cell research has been conducted on animal models," while marketing the same injections to patients as a treatment for autism, Parkinson's disease, cerebral palsy, and blindness — claims the complaint says were not backed by any human clinical studies, including a claim that the therapy restored vision in a 101-year-old patient who had been blind for seven years. The case settled with a $3.31 million judgment. A preclinical result can be a legitimate early step in research, but it is evidence of biological plausibility, not of a safe and effective treatment in humans — and a clinic's citation page should make that distinction clear, not blur it.
Case Series Are Not the Same as Controlled Evidence
Clinics also frequently cite "published" case series — accounts of a handful of patients who were treated and report an outcome, with no control group for comparison. Case series sit near the bottom of the evidence hierarchy used in medicine specifically because they can't rule out whether patients would have improved anyway, from the placebo effect, from a concurrent treatment, or simply over time. A small, uncontrolled case series can be legitimately published and still tell you very little about how a treatment performs on average, or who it might harm. Ask whether a cited study had a comparison group, how many patients were included, and whether it was designed to test effectiveness or just to report that a procedure was performed without immediate complications.
Who Funded and Conducted the Study?
Funding and authorship matter. A study funded by the company selling the product, or authored by physicians with a financial stake in the clinic citing it, isn't automatically wrong — but it should be weighed differently than independent, externally funded research, and a credible citation page will disclose funding sources rather than omit them. Most reputable journals require authors to disclose conflicts of interest in the published article itself; if a clinic's summary doesn't mention funding, check the original paper's disclosure statement.
A Five-Minute Check You Can Do Yourself
Before trusting a clinic's "science" page, it's worth spending a few minutes verifying it directly: search the study title in PubMed to confirm it's genuinely published; read the abstract and methods to see if the population, condition, and cells tested match what's being offered; check whether it was conducted in humans or animals; note whether it had a control group; and look at the funding disclosure. The ISSCR's patient handbook on stem cell treatments recommends asking a clinic directly for the specific published, peer-reviewed evidence supporting the treatment for your condition — not evidence for stem cell therapy in general.
Bottom Line
Citing research is a low bar, and a clinic listing studies on its website tells you very little on its own. What matters is whether those studies were genuinely peer-reviewed, tested in humans, matched to the specific condition and treatment being sold, controlled rather than anecdotal, and transparent about funding. A few minutes on PubMed checking a citation against the claim it's supposed to support is one of the most concrete, actionable ways to tell rigorous evidence from marketing dressed up as science.
Key Questions Answered
- Does a real citation prove a clinic’s treatment works?
- No. The study must also match the condition, cell source, dose and delivery method being offered. Peer review alone does not establish that an unrelated treatment claim is supported.
- Can animal studies or uncontrolled case series establish effectiveness in people?
- Animal and laboratory research can support biological plausibility, not proven human safety and effectiveness. Uncontrolled case series cannot rule out placebo effects, concurrent treatment or improvement over time.
- What should readers check in the original paper?
- Confirm publication and peer review, read the abstract and methods, check whether humans were studied and a comparison group was used, and review funding and conflicts of interest.
Sources
- "FTC Settles Deceptive Advertising Claims Against Amniotic Stem Cell Clinics" — Science-Based Medicine, 2018 — https://sciencebasedmedicine.org/ftc-settles-deceptive-advertising-claims-against-amniotic-stem-cell-clinics/
- "Federal Trade Commission Acts for First Time Against Stem Cell Clinics" — The Pew Charitable Trusts, 2018 — https://www.pew.org/en/research-and-analysis/articles/2018/12/21/federal-trade-commission-acts-for-first-time-against-stem-cell-clinics
- "Important Patient and Consumer Information About Regenerative Medicine Therapies" — U.S. Food and Drug Administration — https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies
- ISSCR Patient Handbook on Stem Cell Treatments (2024 edition) — International Society for Stem Cell Research — https://www.isscr.org/s/ISSCR_PatientHandbook_v12_Feb2024_Redesign_v4b.pdf
- Burns PB, Rohrich RJ, Chung KC. "The Levels of Evidence and Their Role in Evidence-Based Medicine." Plastic and Reconstructive Surgery, 2011 — https://pmc.ncbi.nlm.nih.gov/articles/PMC3124652/
Related Articles
- Research & Industry
J.P. Morgan Healthcare Conference 2027: What Cell and Gene Therapy Watchers Should Expect
Preview JPM Healthcare 2027: conference dates, cell and gene therapy deals, funding signals and why investor sentiment is not clinical evidence.
- Research & Industry
FDA Grants RMAT Designation to a Cell Therapy for Knee Osteoarthritis: What the Placebo-Controlled Data Actually Show
Allocetra’s RMAT designation explained: randomized knee osteoarthritis findings, subgroup limits, missing full data and why designation is not approval.
- Research & Industry
Advanced Therapies Week 2027: What to Know About the Cell and Gene Therapy Industry's Biggest Partnering Event
Advanced Therapies Week returns to San Diego in January 2027, spotlighting manufacturing, partnering and commercialization rather than clinical evidence.